Speaker illustration

Doctor Yasuhiko Sakata

National Cerebral & Cardiovascular Center, Suita (Japan)

Member of:

European Society of Cardiology
Heart Failure Association

After graduating and completing his doctorate at Osaka University, Dr. Sakata studied at Brigham and Women's Hospital. In 2004-2012, he worked as the clinical chief of cardiovascular medicine at Osaka University Hospital and managed the Osaka Acute Coronary Insufficiency Study (N=12,000) as an assistant professor. In 2012-2020, he served as the chief for the CHART-2 study, the largest chronic heart failure cohort study in Japan (N=10,217) as an associate professor at Tohoku University. In 2021, he was appointed Director of the Department of Clinical Medicine and Development at the National Cerebral and Cardiovascular Center, Japan. His areas of expertise include clinical trials, observational studies, and genomic and omics studies, focusing on heart failure and cardiac rehabilitation. Since 2024, he is a visiting professor at Osaka University and a board member of the Japanese Heart Failure Society (JHFS) and the Japanese Association of Cardiac Rehabilitation (JACR).

Does a normal LVEF exist?

Event: Heart Failure 2024

Topic: Clinical

Session: The treatment of heart failure across the ejection fraction spectrum

Thumbnail

EMPEROR-Reduced.

Event: ESC Asia with APSC & AFC 2020

Topic: Chronic Heart Failure

Session: Trial Focus - EMPEROR-Reduced

Thumbnail

Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation and diabetes mellitus -A report from the CHART-2 Study-

Event: Heart Failure 2018

Topic: Clinical, Other

Session: Moderated Poster session 2 - Epidemiology

Thumbnail